Insulin-Degrading Enzyme: A Link Between Alzheimer’s and Type 2 Diabetes Mellitus

Author(s): Rizwanul Haque, Aamir Nazir

Journal Name: CNS & Neurological Disorders - Drug Targets
(Formerly Current Drug Targets - CNS & Neurological Disorders)

Volume 13 , Issue 2 , 2014

Become EABM
Become Reviewer


Enzymes play a very vital role in maintaining the homeostasis inside the body. Improper functioning of enzymes is associated with many diseases. Insulin-degrading enzyme (IDE), a ubiquitously expressed zinc metalloprotease, is believed to act as a junction point of Type 2 Diabetes and Alzheimer’s disease. Recent studies provide inkling for the use of IDE as a potential target hence the design of its regulators would be a viable approach towards treatment of these diseases. This review provides an overview of the IDE structure and function; a relationship is drawn between IDE, Type 2 Diabetes mellitus and Alzheimer’s disease and the approaches that make IDE a potential target, are discussed.

Keywords: Insulin degrading enzyme, Alzheimer’s disease, Type 2 Diabetes mellitus, Caenorhabditis elegans.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Page: [259 - 264]
Pages: 6
DOI: 10.2174/18715273113126660139
Price: $65

Article Metrics

PDF: 84